The Journal of Immunology, Vol 136, Issue 12 4525-4530, Copyright © 1986 by American Association of Immunologists

ARTICLES

Bacterial lipopolysaccharide-induced interferon-gamma production: roles of interleukin 1 and interleukin 2

J Le, JX Lin, D Henriksen-DeStefano and J Vilcek

Bacterial lipopolysaccharide (LPS) induced human peripheral blood mononuclear cells (PBMC) to produce interferon-gamma (IFN-gamma). Monocytes play a mandatory accessory role in this process, because purified T lymphocytes failed to produce IFN-gamma in response to LPS and the addition of 2% monocytes to T cell cultures resulted in an optimal LPS-induced IFN-gamma production. IFN-gamma production was abolished in the presence of monoclonal antibodies specific for HLA-DR antigen. Addition of exogenous interleukin 2 (IL 2) markedly enhanced IFN-gamma secretion by PBMC induced with LPS. The addition of anti-Tac antibody specific for IL 2 receptors abrogated IFN-gamma production, suggesting that an interaction of IL 2 with IL 2 receptors was involved. By using a specific antibody binding assay, LPS was shown to amplify IL 2 receptor expression on PBMC, whereas exogenous IL 2 showed only a negligible enhancing effect on the expression of its own receptors. Interleukin 1 (IL 1), a product of LPS-stimulated monocytes, potentiated IL 2-induced IFN-gamma production in the absence of LPS. Neither IL 1 nor IL 2 alone induced IFN-gamma production in purified T lymphocyte cultures. When added together, however, substantial levels of IFN-gamma were induced. An enhanced IL 2 receptor expression on T cells was also demonstrated as a result of the combined action of IL 1 and IL 2. These results suggest that induction of IFN-gamma by LPS is due mainly to the generation of IL 1 and an enhanced expression of IL 2 receptors.

This article has been cited by other articles:

				O. Umland, H. Heine, M. Miehe, K. Marienfeld, K. H. Staubach, and A. J. Ulmer Induction of various immune modulatory molecules in CD34+ hematopoietic cells J. Leukoc. Biol., April 1, 2004; 75(4): 671 - 679. [Abstract] [Full Text] [PDF]

				S. A. Brod, J. W. Lindsey, F. S. Vriesendorp, C. Ahn, E. Henninger, P. A. Narayana, and J. S. Wolinsky Ingested IFN-{alpha}: Results of a pilot study in relapsing-remitting MS Neurology, September 11, 2001; 57(5): 845 - 852. [Abstract] [Full Text] [PDF]

				T. Merlin, A. Sing, P. J. Nielsen, C. Galanos, and M. A. Freudenberg Inherited IL-12 Unresponsiveness Contributes to the High LPS Resistance of the Lpsd C57BL/10ScCr Mouse J. Immunol., January 1, 2001; 166(1): 566 - 573. [Abstract] [Full Text] [PDF]

				T. Mattern, G. Girroleit, H.-D. Flad, E. T. Rietschel, and A. J. Ulmer CD34+ Hematopoietic Stem Cells Exert Accessory Function in Lipopolysaccharide-induced  T Cell Stimulation and CD80 Expression on Monocytes J. Exp. Med., February 15, 1999; 189(4): 693 - 700. [Abstract] [Full Text] [PDF]

				O. Vayrynen, V. Glumoff, and M. Hallman Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L803 - L810. [Abstract] [Full Text] [PDF]